Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Gross Margin: 2014-2020

Historic Gross Margin for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to 100.00%.

  • Larimar Therapeutics' Gross Margin changed negligibly% to 100.00% in Q1 2020 from the same period last year, while for Mar 2020 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2019, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Larimar Therapeutics reported Gross Margin of 100.00% as of Q1 2020, which was down 0.00% from 100.00% recorded in Q4 2019.
  • Larimar Therapeutics' 5-year Gross Margin high stood at 100.00% for Q1 2016, and its period low was 100.00% during Q1 2016.
  • Its 3-year average for Gross Margin is 100.00%, with a median of 100.00% in 2020.